Cargando…
Progressive multifocal leukoencephalopathy in a patient with multiple myeloma: a case report and analysis of the FDA adverse event reporting system
This paper demonstrates a case of progressive multifocal leukoencephalopathy (PML) in a patient with multiple myeloma (MM) treated with nine different MM therapies. This case report contributes to the already published 16 cases of PML in patients with MM. Additionally, this paper presents an analysi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192558/ https://www.ncbi.nlm.nih.gov/pubmed/37213905 http://dx.doi.org/10.3389/fneur.2023.1098930 |
_version_ | 1785043647930040320 |
---|---|
author | Jonasson, Elise Antulov, Ronald Trøllund Pedersen, Per Sejbæk, Tobias |
author_facet | Jonasson, Elise Antulov, Ronald Trøllund Pedersen, Per Sejbæk, Tobias |
author_sort | Jonasson, Elise |
collection | PubMed |
description | This paper demonstrates a case of progressive multifocal leukoencephalopathy (PML) in a patient with multiple myeloma (MM) treated with nine different MM therapies. This case report contributes to the already published 16 cases of PML in patients with MM. Additionally, this paper presents an analysis of cases from the United States Food and Drug Administration Adverse Event Report System database (n = 117) with a description of demographics and MM-specific therapies. Patients with MM, that developed PML, were treated with immunomodulatory drugs (97%), alkylating agents (52%), and/or proteasome inhibitors (49%). Prior to PML diagnosis, 72% of patients received two or more MM therapies. These results indicate that PML in MM is underreported and could be related to treatment with multiple immunosuppressive therapies rather than MM as a disease itself. Physicians should be aware of potential PML in the late stage of heavily treated MM patients. |
format | Online Article Text |
id | pubmed-10192558 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101925582023-05-19 Progressive multifocal leukoencephalopathy in a patient with multiple myeloma: a case report and analysis of the FDA adverse event reporting system Jonasson, Elise Antulov, Ronald Trøllund Pedersen, Per Sejbæk, Tobias Front Neurol Neurology This paper demonstrates a case of progressive multifocal leukoencephalopathy (PML) in a patient with multiple myeloma (MM) treated with nine different MM therapies. This case report contributes to the already published 16 cases of PML in patients with MM. Additionally, this paper presents an analysis of cases from the United States Food and Drug Administration Adverse Event Report System database (n = 117) with a description of demographics and MM-specific therapies. Patients with MM, that developed PML, were treated with immunomodulatory drugs (97%), alkylating agents (52%), and/or proteasome inhibitors (49%). Prior to PML diagnosis, 72% of patients received two or more MM therapies. These results indicate that PML in MM is underreported and could be related to treatment with multiple immunosuppressive therapies rather than MM as a disease itself. Physicians should be aware of potential PML in the late stage of heavily treated MM patients. Frontiers Media S.A. 2023-05-04 /pmc/articles/PMC10192558/ /pubmed/37213905 http://dx.doi.org/10.3389/fneur.2023.1098930 Text en Copyright © 2023 Jonasson, Antulov, Trøllund Pedersen and Sejbæk. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Jonasson, Elise Antulov, Ronald Trøllund Pedersen, Per Sejbæk, Tobias Progressive multifocal leukoencephalopathy in a patient with multiple myeloma: a case report and analysis of the FDA adverse event reporting system |
title | Progressive multifocal leukoencephalopathy in a patient with multiple myeloma: a case report and analysis of the FDA adverse event reporting system |
title_full | Progressive multifocal leukoencephalopathy in a patient with multiple myeloma: a case report and analysis of the FDA adverse event reporting system |
title_fullStr | Progressive multifocal leukoencephalopathy in a patient with multiple myeloma: a case report and analysis of the FDA adverse event reporting system |
title_full_unstemmed | Progressive multifocal leukoencephalopathy in a patient with multiple myeloma: a case report and analysis of the FDA adverse event reporting system |
title_short | Progressive multifocal leukoencephalopathy in a patient with multiple myeloma: a case report and analysis of the FDA adverse event reporting system |
title_sort | progressive multifocal leukoencephalopathy in a patient with multiple myeloma: a case report and analysis of the fda adverse event reporting system |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192558/ https://www.ncbi.nlm.nih.gov/pubmed/37213905 http://dx.doi.org/10.3389/fneur.2023.1098930 |
work_keys_str_mv | AT jonassonelise progressivemultifocalleukoencephalopathyinapatientwithmultiplemyelomaacasereportandanalysisofthefdaadverseeventreportingsystem AT antulovronald progressivemultifocalleukoencephalopathyinapatientwithmultiplemyelomaacasereportandanalysisofthefdaadverseeventreportingsystem AT trøllundpedersenper progressivemultifocalleukoencephalopathyinapatientwithmultiplemyelomaacasereportandanalysisofthefdaadverseeventreportingsystem AT sejbæktobias progressivemultifocalleukoencephalopathyinapatientwithmultiplemyelomaacasereportandanalysisofthefdaadverseeventreportingsystem |